tiprankstipranks
Trending News
More News >
Concord Biotech Ltd. (IN:CONCORDBIO)
:CONCORDBIO
India Market

Concord Biotech Ltd. (CONCORDBIO) Financial Statements

Compare
1 Followers

Concord Biotech Ltd. Financial Overview

Concord Biotech Ltd.'s market cap is currently ₹220.80B. The company's EPS TTM is ₹13.4; its P/E ratio is 59.42; and it has a dividend yield of 0.42%. Concord Biotech Ltd. is scheduled to report earnings on May 29, 2025, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 25Mar 24Mar 23Mar 22Mar 21
Income Statement
Total Revenue₹ 12.00B₹ 9.98B₹ 8.53B₹ 7.08B₹ 6.04B
Gross Profit₹ 5.89B₹ 7.53B₹ 6.73B₹ 5.31B₹ 4.84B
Operating Income₹ 4.52B₹ 6.26B₹ 3.27B₹ 2.44B₹ 3.07B
EBITDA₹ 5.51B₹ 4.66B₹ 3.83B₹ 2.97B₹ 3.42B
Net Income₹ 3.72B₹ 3.08B₹ 2.40B₹ 1.75B₹ 2.35B
Balance Sheet
Cash & Short-Term Investments₹ 3.18B₹ 2.86B₹ 1.72B₹ 1.62B₹ 2.01B
Total Assets₹ 20.34B₹ 17.01B₹ 15.14B₹ 13.13B₹ 11.83B
Total Debt₹ 29.69M₹ 97.38M₹ 315.47M₹ 624.93M₹ 892.83M
Net Debt₹ 17.86M₹ -54.05M₹ 280.48M₹ 618.26M₹ 841.39M
Total Liabilities₹ 2.22B₹ 1.74B₹ 2.24B₹ 2.10B₹ 1.83B
Stockholders' Equity₹ 18.13B₹ 15.27B₹ 12.90B₹ 11.03B₹ 9.99B
Cash Flow
Free Cash Flow₹ 1.36B₹ 1.80B₹ 1.01B₹ 519.70M₹ -373.59M
Operating Cash Flow₹ 2.47B₹ 2.65B₹ 2.46B₹ 2.07B₹ 1.67B
Investing Cash Flow₹ -1.63B₹ -1.55B₹ -1.58B₹ -1.12B₹ -1.95B
Financing Cash Flow₹ -986.67M₹ -992.15M₹ -852.19M₹ -1.00B₹ 311.24M
Currency in INR

Concord Biotech Ltd. Earnings and Revenue History

Concord Biotech Ltd. Debt to Assets

Concord Biotech Ltd. Cash Flow

Concord Biotech Ltd. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis